NBIX vs SMRT · P/E 45, rev $1.77B vs rev $39.8M
Neurocrine Biosciences Inc (NBIX) versus SmartRent Inc (SMRT) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
SmartRent Inc (SMRT) is a software - application company listed on US.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported SMRT revenue for 2026-06-30 was $39.8M. Net income was -$5.6M. Revenue was up 3.0% from 2026-03-31 to 2026-06-30. SMRT currently screens at market cap $208.9M.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. SMRT currently screens at market cap $208.9M.
Not investment advice. Open the NBIX and SMRT stock pages for the full models.
Not investment advice.